Al-Alao Bassel S, Gately Kathy, Nicholson Siobhan, McGovern Eilis, Young Vincent K, O'Byrne Kenneth J
Thoracic Oncology Research Group, St. James's Hospital, Dublin, Ireland.
Asian Cardiovasc Thorac Ann. 2014 Jan;22(1):55-64. doi: 10.1177/0218492313478431. Epub 2013 Sep 4.
The prognostic significance of vascular and lymphatic invasion in non-small-cell lung cancer is under continuous debate. We analyzed the effect of tumor aggressiveness (lymphatic and/or vessel invasion) on survival and relapse in stage I and II non-small-cell lung cancer.
We retrospectively analyzed prospectively collected data of 457 patients with stage I and II non-small-cell lung cancer from 1998 to 2008. Specimens were analyzed for intratumoral vascular invasion and lymphovascular space invasion. Overall survival and disease-free survival were estimated using the Kaplan-Meier method, and differences were determined by the logrank test. Cox regression analysis was performed to identify independent risk factors.
The incidence of intratumoral vascular invasion was 23.4%, and this correlated significantly with grade of differentiation, visceral pleural involvement, lymphovascular space invasion, and N status. The incidence of lymphovascular space invasion was 5.5%, and this correlated significantly with grade of differentiation, lymph nodes involved, and intratumoral vascular invasion. On multivariate analyses, intratumoral vascular invasion proved to be an significant independent risk factor for overall survival but not for disease-free survival. Lymphovascular space invasion was associated significantly with early tumor recurrence but not with overall survival.
Vascular and lymphatic invasion can serve as independent prognostic factors in completely resected non-small-cell lung cancer. Intratumoral vascular invasion and lymphovascular space invasion in early stage non-small-cell lung cancer are important factors in overall survival and early tumor recurrence. Further large scale studies with more recent patient cohorts and refined histological techniques are warranted.
血管和淋巴管侵犯在非小细胞肺癌中的预后意义一直存在争议。我们分析了肿瘤侵袭性(淋巴管和/或血管侵犯)对Ⅰ期和Ⅱ期非小细胞肺癌患者生存和复发的影响。
我们回顾性分析了1998年至2008年期间前瞻性收集的457例Ⅰ期和Ⅱ期非小细胞肺癌患者的数据。对标本进行瘤内血管侵犯和淋巴管腔侵犯分析。采用Kaplan-Meier法估计总生存期和无病生存期,并通过对数秩检验确定差异。进行Cox回归分析以确定独立危险因素。
瘤内血管侵犯的发生率为23.4%,这与分化程度、脏层胸膜受累、淋巴管腔侵犯和N分期显著相关。淋巴管腔侵犯的发生率为5.5%,这与分化程度、受累淋巴结和瘤内血管侵犯显著相关。多因素分析显示,瘤内血管侵犯是总生存期的一个重要独立危险因素,但不是无病生存期的独立危险因素。淋巴管腔侵犯与肿瘤早期复发显著相关,但与总生存期无关。
血管和淋巴管侵犯可作为完全切除的非小细胞肺癌的独立预后因素。早期非小细胞肺癌的瘤内血管侵犯和淋巴管腔侵犯是总生存期和肿瘤早期复发的重要因素。有必要对更多近期患者队列和更精细的组织学技术进行进一步的大规模研究。